Eva Gimeno

1.4k total citations
38 papers, 360 citations indexed

About

Eva Gimeno is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Eva Gimeno has authored 38 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 12 papers in Genetics and 11 papers in Oncology. Recurrent topics in Eva Gimeno's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Eva Gimeno is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Eva Gimeno collaborates with scholars based in Spain, Greece and United Kingdom. Eva Gimeno's co-authors include Antonio Salar, Blanca Sánchez‐González, Beatríz Bellosillo, Eugènia Abella, Carles Besses, Sergi Serrano, Françesc Solé, Alberto Álvarez‐Larrán, Carmen Pedro and Josep Franch‐Nadal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Eva Gimeno

34 papers receiving 353 citations

Peers

Eva Gimeno
Monika Długosz‐Danecka Poland
Lidia Usnarska‐Zubkiewicz Poland
Başak Oyan Türkiye
Bosko Andjelic Serbia
Bobin Chen China
Francesca Palombi Italy
Satoru Tsunoda Japan
Rutger Maas Netherlands
Dìlek Dìnçol Türkiye
W.A. van Deijk Netherlands
Monika Długosz‐Danecka Poland
Eva Gimeno
Citations per year, relative to Eva Gimeno Eva Gimeno (= 1×) peers Monika Długosz‐Danecka

Countries citing papers authored by Eva Gimeno

Since Specialization
Citations

This map shows the geographic impact of Eva Gimeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Gimeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Gimeno more than expected).

Fields of papers citing papers by Eva Gimeno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Gimeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Gimeno. The network helps show where Eva Gimeno may publish in the future.

Co-authorship network of co-authors of Eva Gimeno

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Gimeno. A scholar is included among the top collaborators of Eva Gimeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Gimeno. Eva Gimeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Helen, et al.. (2026). Exploring the synergy between telomere length and genomic complexity in CLL. British Journal of Haematology. 208(3). 1121–1126.
2.
Rodríguez‐Sevilla, Juan José, Concepción Fernández‐Rodríguez, Leyre Bento, et al.. (2022). Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy. Blood Advances. 7(8). 1606–1614. 8 indexed citations
3.
Vázquez, Ivonne, Anna Puiggros, Blanca Sánchez‐González, et al.. (2021). Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1073–1078. 2 indexed citations
4.
Rodríguez‐Sevilla, Juan José, Luís Colomo, Eva Gimeno, et al.. (2021). Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome. Thrombosis Research. 208. 226–229. 1 indexed citations
5.
Puiggros, Anna, Gonzalo Blanco, Aura Muntasell, et al.. (2021). Reduced expansion of CD94/NKG2C+ NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions. International Journal of Laboratory Hematology. 43(5). 1032–1040. 7 indexed citations
6.
Martín‐Ontiyuelo, Clara, et al.. (2019). Hypermetabolic bone on 18F-FDG-PET/CT in a patient with lung cancer: Is it always metastasis?. Archivos de Bronconeumología. 56(1). 51–52. 1 indexed citations
7.
Blanco, Gonzalo, Anna Vardi, Anna Puiggros, et al.. (2018). Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL. OncoImmunology. 7(6). e1432328–e1432328. 21 indexed citations
8.
Sánchez‐González, Blanca, Montserrat Garcı́a-Retortillo, Francesc García‐Pallarols, et al.. (2016). Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy. Blood. 128(22). 1801–1801. 1 indexed citations
9.
Puiggros, Anna, Eulàlia Puigdecanet, Marta Salido, et al.. (2012). Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescencein situhybridization techniques?. Leukemia & lymphoma. 54(5). 986–995. 10 indexed citations
10.
García, M. García, Beatríz Bellosillo, Blanca Sánchez‐González, et al.. (2012). Study of Regulatory T-Cells in Patients with Gastric Malt Lymphoma: Influence on Treatment Response and Outcome. PLoS ONE. 7(12). e51681–e51681. 34 indexed citations
11.
Gimeno, Eva, Miquel Gómez, Juan R. González, et al.. (2011). NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma. Leukemia Research. 35(6). 715–720. 31 indexed citations
12.
Lanas, Ángel, et al.. (2011). Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care. Gastroenterología y Hepatología. 35(1). 1–7. 6 indexed citations
13.
Pérez, Antonio, Josep Franch‐Nadal, Aleix Cases, et al.. (2011). Relación del grado de control glucémico con las características de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES. Medicina Clínica. 138(12). 505–511. 41 indexed citations
14.
Gimeno, Eva, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, et al.. (2010). Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma. Leukemia Research. 35(3). 358–362. 16 indexed citations
15.
Salar, Antonio, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, et al.. (2009). NT-ProBNP prediction of major chemotherapy-related toxicity and death in lymphoma patients. Journal of Clinical Oncology. 27(15_suppl). 9569–9569. 2 indexed citations
16.
Álvarez‐Larrán, Alberto, Beatríz Bellosillo, Luz Martínez‐Avilés, et al.. (2009). Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients. British Journal of Haematology. 146(5). 504–509. 35 indexed citations
17.
Abella, Eugènia, Javier Gimeno, Carmen Pedro, et al.. (2008). Diarrheic syndrome as a clinical sign of intestinal infiltration in progressive B-cell chronic lymphocytic leukemia. Leukemia Research. 33(1). 159–161. 6 indexed citations
18.
Piccaluga, Pier Paolo, Andrea Califano, Ulf Klein, et al.. (2008). Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica. 93(7). 1033–1038. 51 indexed citations
19.
20.
Marrón, S.E. & Eva Gimeno. (1997). Early detection and treatment program of malignant melanoma in the Calatayud hospital. Melanoma Research. 7(Supplement 1). S75–S75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Długosz‐Danecka Breakdown of academic impact, for papers by Lidia Usnarska‐Zubkiewicz Breakdown of academic impact, for papers by Başak Oyan Breakdown of academic impact, for papers by Bosko Andjelic Breakdown of academic impact, for papers by Bobin Chen Breakdown of academic impact, for papers by Francesca Palombi Breakdown of academic impact, for papers by Satoru Tsunoda Breakdown of academic impact, for papers by Rutger Maas Breakdown of academic impact, for papers by Dìlek Dìnçol Breakdown of academic impact, for papers by W.A. van Deijk
Rankless by CCL
2026